Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Abbott Laboratories (ABT)

Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

The 3 Most Powerful Dividend Kings You’ve Probably Overlooked

Dividend stocks have always been a go-to choice for income investors. However, some are shifting away from dividend stocks, opting for other investments that offer higher returns in a shorter timeframe. But that strategy is typically not repeatable - at least not for most traders. 

For those who prefer stability and security, like myself, Dividend Kings almost always make a great addition to one’s portfolio. These are companies with 50 or more years of consistent dividend increases. They often add a sense of stability during times of volatility as investors tend to keep these stocks so long as they continue...

Fundamentals

See More
  • Market Capitalization, $K 232,407,296
  • Shares Outstanding, K 1,739,836
  • Annual Sales, $ 41,950 M
  • Annual Income, $ 13,402 M
  • EBIT $ 8,958 M
  • EBITDA $ 12,176 M
  • 60-Month Beta 0.74
  • Price/Sales 5.51
  • Price/Cash Flow 20.18
  • Price/Book 4.71

Options Overview Details

View History
  • Implied Volatility 23.43% ( +0.77%)
  • Historical Volatility 17.72%
  • IV Percentile 68%
  • IV Rank 33.20%
  • IV High 42.50% on 04/07/25
  • IV Low 13.95% on 11/27/24
  • Put/Call Vol Ratio 0.60
  • Today's Volume 9,529
  • Volume Avg (30-Day) 9,158
  • Put/Call OI Ratio 0.78
  • Today's Open Interest 199,844
  • Open Int (30-Day) 199,464

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 25 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/25
See More
  • Average Estimate 1.25
  • Number of Estimates 9
  • High Estimate 1.26
  • Low Estimate 1.24
  • Prior Year 1.14
  • Growth Rate Est. (year over year) +9.65%

Price Performance

See More
Period Period Low Period High Performance
1-Month
128.00 +4.36%
on 05/01/25
136.80 -2.35%
on 05/02/25
+2.83 (+2.16%)
since 04/30/25
3-Month
120.47 +10.88%
on 04/07/25
141.23 -5.42%
on 03/04/25
-4.43 (-3.21%)
since 02/28/25
52-Week
99.71 +33.97%
on 07/18/24
141.23 -5.42%
on 03/04/25
+31.63 (+31.03%)
since 05/28/24

Most Recent Stories

More News
The 3 Most Powerful Dividend Kings You’ve Probably Overlooked

These three Dividend Kings have strong cash flow and EPS growth, making a compelling case for long-term income investors.

ABT : 133.58 (+0.55%)
PH : 664.70 (-0.38%)
SPGI : 512.86 (-0.24%)
The Zacks Analyst Blog Highlights Coca-Cola, Abbott Laboratories and AT&T

For Immediate ReleaseChicago, IL – May 28, 2025 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events...

ABT : 133.58 (+0.55%)
T : 27.80 (+1.53%)
KO : 72.10 (+0.85%)
Top Stock Reports for Coca-Cola, Abbott & AT&T

Tuesday, May 27, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including The Coca-Cola Co....

ABT : 133.58 (+0.55%)
T : 27.80 (+1.53%)
KO : 72.10 (+0.85%)
CNC : 56.44 (-0.14%)
VALE : 9.13 (-3.28%)
HMC : 30.52 (-0.07%)
These 3 Dividend Kings Could Supercharge Your Retirement Income

Discover the 3 Dividend Kings quietly delivering massive payout growth while others barely move the needle.

ABT : 133.58 (+0.55%)
LOW : 225.73 (+0.36%)
PH : 664.70 (-0.38%)
2 Dividend Stocks to Buy With $500 and Hold Forever

ABT : 133.58 (+0.55%)
ZTS : 168.63 (+0.89%)
Abbott vs. Medtronic: Which Dividend-Paying MedTech Stock is Better?

Abbott ABT and Medtronic MDT, two leading giants in the global medical device space, are demonstrating strong momentum in 2025 despite various macroeconomic challenges, including significant tariff pressures.Medtronic...

ABT : 133.58 (+0.55%)
MDT : 82.98 (+0.69%)
3 Dividend Aristocrats Quietly Dominating The Market in 2025

These three dividend stocks easily beat the S&P 500's return in 2025 while offering predictable earnings and dividend growth.

ABT : 133.58 (+0.55%)
CAH : 154.44 (+0.29%)
ECL : 265.62 (+0.50%)
Abbott Reveals Positive Outcome From REFLECT Studies, Stock Climbs

Abbott ABT recently announced results from its REFLECT real-world studies, conducted using data from the comprehensive Swedish National Diabetes Register. The findings revealed that the company’s FreeStyle...

ABT : 133.58 (+0.55%)
BSX : 105.26 (+0.73%)
HIMS : 56.56 (+7.94%)
CAH : 154.44 (+0.29%)
3 Magnificent Stocks That Are Passive Income Machines

ABT : 133.58 (+0.55%)
JNJ : 155.21 (+1.06%)
ABBV : 186.11 (+0.26%)
3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

ABT : 133.58 (+0.55%)
KO : 72.10 (+0.85%)
MCD : 313.85 (+0.64%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures...

See More

Key Turning Points

3rd Resistance Point 136.94
2nd Resistance Point 135.53
1st Resistance Point 134.56
Last Price 133.58
1st Support Level 132.17
2nd Support Level 130.76
3rd Support Level 129.79

See More

52-Week High 141.23
Last Price 133.58
Fibonacci 61.8% 125.37
Fibonacci 50% 120.47
Fibonacci 38.2% 115.57
52-Week Low 99.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar